Updated FDA Guidelines for Drug Development for Opioid Use Disorders
With the rise in opioid use disorders due to the COVID pandemic, the agency is re-examining drug development goals.COVID-19 has received all the attention this year, but, sadly, that doesn't mean other health crises are gone,…